These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10783118)

  • 1. Absence of antibody against human papillomavirus type 16 E6 and E7 in patients with cervical cancer is independent of sequence variations.
    Nindl I; Zumbach K; Pawlita M; Teller K; Schneider A; Dürst M
    J Infect Dis; 2000 May; 181(5):1764-7. PubMed ID: 10783118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer.
    Fisher SG; Benitez-Bribiesca L; Nindl I; Stockfleth E; Muller M; Wolf H; Perez-Garcia F; Guzman-Gaona J; Gutierrez-Delgado F; Irvin W; Gissmann L
    Gynecol Oncol; 1996 Apr; 61(1):73-8. PubMed ID: 8626121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV-16-related proteins as the serologic markers in cervical neoplasia.
    Park JS; Park DC; Kim CJ; Ahn HK; Um SJ; Park SN; Kim SJ; Namkoong SE
    Gynecol Oncol; 1998 Apr; 69(1):47-55. PubMed ID: 9570998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus-related serological markers of invasive cervical carcinoma in Brazil.
    Sun Y; Eluf-Neto J; Bosch FX; Muñoz N; Booth M; Walboomers JM; Shah KV; Viscidi RP
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):341-7. PubMed ID: 8061584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patients.
    Nindl I; Benitez-Bribiesca L; Berumen J; Farmanara N; Fisher S; Gross G; Lopez-Carillo L; Müller M; Tommasino M; Vazquez-Curiel A
    Arch Virol; 1994; 137(3-4):341-53. PubMed ID: 7524466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease.
    Frazer IH; Leippe DM; Dunn LA; Liem A; Tindle RW; Fernando GJ; Phelps WC; Lambert PF
    Cancer Res; 1995 Jun; 55(12):2635-9. PubMed ID: 7540107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological study in Tunisian cervical cancer patients.
    Achour M; Kochbati L; Zeghal D; Kahla S; Maalej M; Zouari F; Oueslati R
    Pathol Biol (Paris); 2009 Jul; 57(5):415-9. PubMed ID: 18586408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions.
    Cento V; Ciccozzi M; Ronga L; Perno CF; Ciotti M
    J Med Virol; 2009 Sep; 81(9):1627-34. PubMed ID: 19626616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients.
    Silins I; Avall-Lundqvist E; Tadesse A; Jansen KU; Stendahl U; Lenner P; Zumbach K; Pawlita M; Dillner J; Frankendal B
    Gynecol Oncol; 2002 May; 85(2):333-8. PubMed ID: 11972397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of seroreactive epitopes of human papillomavirus type 18 E7 protein by synthetic peptides.
    Krchnák V; Pistĕk T; Vágner J; Suchánková A; Kañka J; Ritterová L; Vonka V
    Acta Virol; 1993 Oct; 37(5):395-402. PubMed ID: 7514354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scanning the structure and antigenicity of HPV-16 E6 and E7 oncoproteins using antipeptide antibodies.
    Stacey SN; Eklund C; Jordan D; Smith NK; Stern PL; Dillner J; Arrand JR
    Oncogene; 1994 Feb; 9(2):635-45. PubMed ID: 7507231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of peptide enzyme-linked immunosorbent assay and radioimmunoprecipitation assay with in vitro-translated proteins for detection of serum antibodies to human papillomavirus type 16 E6 and E7 proteins.
    Sun Y; Shah KV; Müller M; Muñoz N; Bosch XF; Viscidi RP
    J Clin Microbiol; 1994 Sep; 32(9):2216-20. PubMed ID: 7529250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
    de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
    Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients.
    Ravaggi A; Romani C; Pasinetti B; Tassi RA; Bignotti E; Bandiera E; Odicino FE; Ragnoli M; Donzelli C; Falchetti M; Calza S; Santin AD; Pecorelli S
    Arch Virol; 2006 Oct; 151(10):1899-916. PubMed ID: 16732494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of HPV-18 and variants of E6 gene isolated from cervical cancer patients in Taiwan.
    Chang CH; Chen TH; Hsu RC; Chou PH; Yang JJ; Hwang GY
    J Clin Virol; 2005 Jan; 32(1):33-7. PubMed ID: 15572004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer.
    Hamada K; Shirakawa T; Gotoh A; Roth JA; Follen M
    Gynecol Oncol; 2006 Dec; 103(3):820-30. PubMed ID: 16908054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of high-risk human papillomavirus (HPV) E6 and E7 oncogene transcripts increases the specificity of the detection of a cervical intraepithelial neoplasia (CIN)].
    Sotlar K; Diemer D; Stubner A; Menton S; Menton M; Dietz K; Wallwiener D; Bültmann B
    Verh Dtsch Ges Pathol; 2005; 89():195-200. PubMed ID: 18035691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between HPV-16 serology and clinico-pathological data in cervical carcinoma patients: prognostic value of anti-E6 and/or anti-E7 antibodies.
    Baay MF; Duk JM; Groenier KH; Burger MP; de Bruijn HW; Hollema H; Stolz E; Herbrink P
    Cancer Immunol Immunother; 1997 Jun; 44(4):211-5. PubMed ID: 9222279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.